Molina Healthcare

Sycamore Capital named Molina Healthcare its top contributor in Q2 after shares rallied on a strong 1Q26 earnings report that suggested medical cost ratio deterioration may be behind the company. Greater visibility into the timing and scale of Medicaid spending cuts under the "One Big Beautiful Bill Act" and favorable CMS 2025 risk‑adjustment transfer data further lifted the stock. Molina closed Aug. 12 at $206.06, with a market cap of $10.76 billion, a year‑to‑date gain of 20.40%, one‑month return of -7.06% and 52‑week gain of 30.90%. » Więcej na finance.yahoo.com

Molina Healthcare beat adjusted EPS in Q2 but disappointed with an unchanged full-year revenue forecast of about $42 billion, well below consensus. CEO Joseph Zubretsky said 2026 could be a trough year for pre-tax margins in the Medicaid business. Additional pressure came from falling membership, problems with Marketplace enrollments and ramp-up costs on the Florida CMS Medicaid contract, causing the stock to plunge in premarket trading. » Więcej na de.investing.com

Bloomberg options market data indicate that Molina Healthcare’s stock had priced in an implied move of about 11% for July 23 after the close. In four of the last eight quarters the actual stock move exceeded the implied volatility—most recently moves of 18.4% (April 22) and 29.6% (February 5), as well as several declines that were significantly larger than expected. In the remaining quarters the stock fell short of the expected moves, pointing to mixed market reactions to the earnings. » Więcej na de.investing.com